Montana's Right-to-Try Experiment
A new state law lets biotech companies sell drugs that have cleared only the smallest, earliest phase of testing — no FDA approval required. Supporters call it a lifeline for patients out of options. Critics call it a $12,500-application-fee shortcut around the system that keeps medicine safe.
Novo Nordisk's Oral Semaglutide Hits the Mark in Landmark Pediatric Diabetes Trial
The PIONEER TEENS Phase 3 trial delivered statistically significant blood sugar improvements in children as young as 10 — and could bring the first pill-based GLP-1 therapy to young people with type 2 diabetes.
Louisiana's Abortion Pill Case Could Wipe Out Access in Blue States
Louisiana will argue before a federal appeals court that FDA rules allowing telehealth prescription and mail delivery of mifepristone infringe on its right to prohibit abortion — but if it succeeds, it would wipe out online and mail access in states where abortion is legal, cutting off millions from a method they increasingly depend on.
Nine More Drugmakers Just Signed On to Lower U.S. Drug Prices — Here's What It Actually Means for You
Teva, CSL, Astellas, UCB and five other manufacturers have agreed to "most-favored-nation" pricing, bringing the total to 26 companies. The savings are real — but experts say most of them won't show up at your pharmacy counter just yet.
Sarcoidosis: When Inflammation Builds Tiny Clumps in the Body
Sarcoidosis is a disease in which the immune system forms small clusters of inflammatory cells — called granulomas — in one or more organs, most often the lungs. Its course is unpredictable: it can quietly fade on its own or become a long-term condition.
Sickle Cell Disease: An Inherited Change in the Blood
Sickle cell disease is a genetic blood disorder that reshapes red blood cells into stiff crescents that block blood flow and break down too soon. It's a lifelong condition — but care has advanced dramatically, and the first curative therapies are now a reality.